North Central Neurology Associates

Cullman, Alabama 35058

0 studies enrolling now · 6 studies all time

What they study most

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Progressive Multifocal Leukoencephalopathy, Relapsing Forms of Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis — Completed
• Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis — Paused
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed
• Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy — Stopped early